Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1981 1
1985 1
1986 1
1987 1
1989 3
1990 1
1991 2
1994 2
1995 1
1996 2
1997 2
1998 4
1999 1
2001 2
2002 2
2003 3
2004 1
2005 1
2006 1
2010 1
2011 1
2012 1
2014 5
2015 4
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
KRAS and BRAF mutations in anal carcinoma.
Serup-Hansen E, Linnemann D, Høgdall E, Geertsen PF, Havsteen H. Serup-Hansen E, et al. Among authors: havsteen h. APMIS. 2015 Jan;123(1):53-9. doi: 10.1111/apm.12306. Epub 2014 Sep 22. APMIS. 2015. PMID: 25244542
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
Nordsmark M, Loncaster J, Chou SC, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA. Nordsmark M, et al. Among authors: havsteen h. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):581-6. doi: 10.1016/s0360-3016(00)01493-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173158
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
Mahner S, Meier W, du Bois A, Brown C, Lorusso D, Dell'Anna T, Cretin J, Havsteen H, Bessette P, Zeimet AG, Vergote I, Vasey P, Pujade-Lauraine E, Gladieff L, Ferrero A. Mahner S, et al. Among authors: havsteen h. Eur J Cancer. 2015 Feb;51(3):352-8. doi: 10.1016/j.ejca.2014.11.017. Epub 2014 Dec 17. Eur J Cancer. 2015. PMID: 25534295 Clinical Trial.
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.
Lindemann K, Christensen RD, Vergote I, Stuart G, Izquierdo MA, Kærn J, Havsteen H, Eisenhauer E, Ridderheim M, Lopez AB, Hirte H, Aavall-Lundquvist E, Vrdoljak E, Green J, Kristensen GB. Lindemann K, et al. Among authors: havsteen h. Ann Oncol. 2012 Oct;23(10):2613-2619. doi: 10.1093/annonc/mds060. Epub 2012 Apr 26. Ann Oncol. 2012. PMID: 22539562 Free article. Clinical Trial.
45 results